Glipizide Tablet
Product Images NDC 72789-130

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 72789-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789130 Label (72789130)

72789130 Label (72789130)
Label for Glipizide USP 5 mg oral tablets by PD-Rx Pharmaceuticals, Inc., packaging contains 90 tablets. The label includes the NDC 72789-130-90, lot number C22C84, expiration date 02/2024, and a warning to keep out of reach of children with dosage and storage instructions referenced. Information is presented in both English and Spanish.*
FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Glipizide-structure.jpg (Glipizide Structure)
Chemical structure of Glipizide, showing its molecular composition with a heterocyclic ring, aromatic benzene ring, sulfonyl group, and cyclohexane ring as part of its chemical framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.